Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03785977 · ClinicalTrials.gov registry record
Airway Deadspace in Children: Air-Q Versus Endotracheal Tube
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 62
- Enrollment target
NCT03785977: Completed study, sponsored by Wake Forest University Health Sciences.
NCT03785977 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03785977 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
The objective of this study will be to measure the airway deadspace associated with use of appropriately sized an AirQ, a commonly used supraglottic airway in young children weighing between 5 and 20 kg and compare that to the airway deadspace associated with use of an endotracheal tube (ETT) in similarly sized children undergoing controlled ventilation.
Primary Outcome
A mean value observed over the first 10 minutes following placement of the ETT or the AirQ at the beginning of the case will be recorded.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2019-03-25 |
| Est. Completion | 2019-08-09 |
What the finished NCT03785977 record still lists
NCT03785977 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03785977 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03785977 about?
NCT03785977 is a clinical study titled "Airway Deadspace in Children: Air-Q Versus Endotracheal Tube". The objective of this study will be to measure the airway deadspace associated with use of appropriately sized an AirQ, a commonly used supraglottic airway in young children weighing between 5 and 20 kg and compare that to the airway deadspace associated with use of an endotracheal tube (ETT) in sim...
What is the current status of trial NCT03785977?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2019-03-25. Estimated completion is 2019-08-09.
Who is sponsoring clinical trial NCT03785977?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI